Source summary (excerpt): “The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.”
Sourcing: single source, treat as unconfirmed until corroborated.
MarketsBRIEF
Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
CNBC reported on Fri Nov 6, 5:56 AM CT, unconfirmed by other outlets so far: Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction.
What happened
Reported from CNBC. Site-only brief: it was not posted on X.